Patents by Inventor Matthew S. Miller

Matthew S. Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Surgical instrument with selectively actuated gap-setting features for end effector
    Patent number: 11963691
    Abstract: A surgical instrument, has an end effector that includes an ultrasonic blade, and a clamp arm that moves relative to the ultrasonic blade from an opened position toward an intermediate position and a closed position. The clamp arm is offset from the ultrasonic blade to define a predetermined gap in the intermediate position between the opened position and the closed position. A clamp arm actuator connects to the clamp arm and moves from an opened configuration to a closed configuration to direct the clamp arm from the opened position toward the intermediate position and the closed position. A spacer connects with the clamp arm to inhibit movement of the clamp arm from the intermediate position toward the closed position for maintaining the predetermined gap between the clamp arm and the ultrasonic blade.
    Type: Grant
    Filed: December 21, 2020
    Date of Patent: April 23, 2024
    Assignee: Cilag GmbH International
    Inventors: Ryan M. Asher, Brian D. Black, John E. Brady, Joseph Dennis, Geni M. Giannotti, Bryce L. Heitman, Timothy S. Holland, Joseph E. Hollo, Andrew Kolpitcke, Amy M. Krumm, Jason R. Lesko, Matthew C. Miller, David A. Monroe, Ion V. Nicolaescu, Rafael J. Ruiz Ortiz, Matthew S. Schneider, Richard C. Smith, Shawn C. Snyder, Sarah A. Worthington, Monica L. Rivard, Fajian Zhang
  • HOME RENAL THERAPY SYSTEM AND MACHINE
    Publication number: 20240091422
    Abstract: A renal therapy system is disclosed. In an example, the renal therapy system includes a home renal therapy machine that stores, to a log file, dates of when renal therapies were performed and a type of each renal therapy that was performed. The system also includes a server that receives the log file from the home renal therapy machine. The server compares the dates and types of performed renal therapies stored in the log file to a device program that specifies dates for performing renal therapies and the types of renal therapies to be performed. The server displays a flag in a user interface of a clinician computer when there is a deviation from the comparison.
    Type: Application
    Filed: November 20, 2023
    Publication date: March 21, 2024
    Inventors: Neil Tiwari, Joshua James Miller, Marc Steven Minkus, Matthew R. Muller, Derek Wiebenson, Douglas L. Wilkerson, Timothy G. Robinson, Anders J. Wellings, Kathryn Louise Hansbro, Borut Cizman, Brian S. Kunzeman, Robin D. Cooper, Timothy L. Kudelka, Angelo A. Sarto, Steve Joseph Lindo, Jostein Baustad, Duston Mounts, Shafali Hill
  • SURGICAL ACCESS DEVICES AND METHODS PROVIDING SEAL MOVEMENT IN PREDEFINED MOVEMENT REGIONS
    Publication number: 20240081802
    Abstract: Various methods and devices are provided for allowing multiple surgical instruments to be inserted into sealing elements of a single surgical access device. The sealing elements can be movable along predefined pathways within the device to allow surgical instruments inserted through the sealing elements to be moved laterally, rotationally, angularly, and vertically relative to a central longitudinal axis of the device for ease of manipulation within a patient's body while maintaining insufflation.
    Type: Application
    Filed: November 16, 2023
    Publication date: March 14, 2024
    Inventors: Mark S. Ortiz, David T. Martin, Matthew C. Miller, Mark J. Reese, Wells D. Haberstich, Carl Shurtleff, Charles J. Scheib, Frederick E. Shelton, IV, Jerome R. Morgan, Daniel H. Duke, Daniel J. Mumaw, Gregory W. Johnson, Kevin L. Houser
  • Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
    Patent number: 7087647
    Abstract: Modafinil is effective in improving symptoms of attention deficit hyperactivity disorder and symptoms of multiple sclerosis fatigue. The administration of modafinil is also shown to activate the tuberomamillary neurons of the posterior hypothalamus, and thus exhibits activity in an area of the brain associated with normal wakefulness functions.
    Type: Grant
    Filed: October 30, 2002
    Date of Patent: August 8, 2006
    Assignee: Cephalon, Inc.
    Inventors: Matthew S. Miller, Thomas E. Scammell
  • Methods for the treatment and prevention of pain
    Patent number: 7018999
    Abstract: Novel methods for the treatment and/or prevention of pain are presented. The methods may comprise administering to a subject in need thereof an effective amount of a stress-activated protein kinase inhibitor. Preferred compounds for use in the methods include fused pyrrolocarbazole compounds.
    Type: Grant
    Filed: May 15, 2002
    Date of Patent: March 28, 2006
    Assignee: Cephalon, Inc.
    Inventors: Lisa D. Aimone, Robert L. Hudkins, Matthew S. Miller
  • Substituted thioacetamides
    Patent number: 6919367
    Abstract: The present invention is directed to chemical compositions of substituted thioacetamides, processes for the preparation thereof and uses of the compositions in the treatment of diseases.
    Type: Grant
    Filed: November 18, 2003
    Date of Patent: July 19, 2005
    Assignee: Cephalon, Inc.
    Inventors: Edward R. Bacon, Sankar Chatterjee, Derek Dunn, John P. Mallamo, Matthew S. Miller, Rabindranath Tripathy, Jeffry L. Vaught
  • Substituted thioacetamides
    Publication number: 20040116445
    Abstract: The present invention is directed to chemical compositions of substituted thioacetamides, processes for the preparation thereof and uses of the compositions in the treatment of diseases.
    Type: Application
    Filed: November 18, 2003
    Publication date: June 17, 2004
    Inventors: Edward R. Bacon, Sankar Chatterjee, Derek Dunn, John P. Mallamo, Matthew S. Miller, Rabindranath Tripathy, Jeffry L. Vaught
  • Substituted thioacetamides
    Patent number: 6670358
    Abstract: The present invention is directed to chemical compositions of substituted thioacetamides, processes for the preparation thereof and uses of the compositions in the treatment of diseases.
    Type: Grant
    Filed: October 26, 2001
    Date of Patent: December 30, 2003
    Assignee: Cephalon, Inc.
    Inventors: Edward R. Bacon, Sankar Chatterjee, Derek Dunn, John P. Mallamo, Matthew S. Miller, Rabindranath Tripathy, Jeffry L. Vaught
  • Novel methods for the treatment and prevention of pain
    Publication number: 20030087899
    Abstract: Novel methods for the treatment and/or prevention of pain are presented. The methods may comprise administering to a subject in need thereof an effective amount of a stress-activated protein kinase inhibitor. Preferred compounds for use in the methods include fused pyrrolocarbazole compounds.
    Type: Application
    Filed: May 15, 2002
    Publication date: May 8, 2003
    Applicant: Cephalon, Inc
    Inventors: Lisa D. Aimone, Robert L. Hudkins, Matthew S. Miller
  • Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
    Publication number: 20030069313
    Abstract: Modafinil is effective in improving symptoms of attention deficit hyperactivity disorder and symptoms of multiple sclerosis fatigue. The administration of modafinil is also shown to activate the tuberomamillary neurons of the posterior hypothalamus, and thus exhibits activity in an area of the brain associated with normal wakefulness functions.
    Type: Application
    Filed: October 30, 2002
    Publication date: April 10, 2003
    Applicant: Cephalon, Inc.
    Inventors: Matthew S. Miller, Thomas E. Scammell
  • Substituted thioacetamides
    Patent number: 6492396
    Abstract: The present invention is directed to chemical compositions of substituted thioacetamides, processes for the preparation thereof and uses of the compositions in the treatment of diseases.
    Type: Grant
    Filed: May 15, 2001
    Date of Patent: December 10, 2002
    Assignee: Cephalon, Inc.
    Inventors: Edward R. Bacon, Sankar Chatterjee, Derek Dunn, John P. Mallamo, Jeffry L. Vaught, Matthew S. Miller
  • Substituted thioacetamides
    Publication number: 20020183334
    Abstract: The present invention is directed to chemical compositions of substituted thioacetamides, processes for the preparation thereof and uses of the compositions in the treatment of diseases.
    Type: Application
    Filed: October 26, 2001
    Publication date: December 5, 2002
    Inventors: Edward R. Bacon, Sankar Chatterjee, Derek Dunn, John P. Mallamo, Matthew S. Miller, Rabindranath Tripathy, Jeffry L. Vaught
  • Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
    Patent number: 6488164
    Abstract: Modafinil is effective in improving symptoms of attention deficit hyperactivity disorder and symptoms of multiple sclerosis fatigue. The administration of modafinil is also shown to activate the tuberomamillary neurons of the posterior hypothalamus, and thus exhibits activity in an area of the brain associated with normal wakefulness functions.
    Type: Grant
    Filed: December 20, 2001
    Date of Patent: December 3, 2002
    Assignee: Cephalon, Inc.
    Inventors: Matthew S. Miller, Thomas E. Scammell
  • Compositions including modafinil for treatment of eating disorders and for appetite stimulation
    Patent number: 6455588
    Abstract: Modafinil is effective in improving symptoms of eating disorders or in stimulating appetite.
    Type: Grant
    Filed: August 17, 2000
    Date of Patent: September 24, 2002
    Assignee: Cephalon, Inc.
    Inventors: Thomas E. Scammell, Matthew S. Miller
  • Compositions including modafinil for treatment of eating disorders and for appetite stimulation
    Publication number: 20020128322
    Abstract: Modafinil is effective in improving symptoms of eating disorders or in stimulating appetite.
    Type: Application
    Filed: May 2, 2002
    Publication date: September 12, 2002
    Inventors: Thomas E. Scammell, Matthew S. Miller
  • Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
    Publication number: 20020082301
    Abstract: Modafinil is effective in improving symptoms of attention deficit hyperactivity disorder and symptoms of multiple sclerosis fatigue. The administration of modafinil is also shown to activate the tuberomamillary neurons of the posterior hypothalamus, and thus exhibits activity in an area of the brain associated with normal wakefulness functions.
    Type: Application
    Filed: December 20, 2001
    Publication date: June 27, 2002
    Applicant: Cephalon, Inc.
    Inventors: Matthew S. Miller, Thomas E. Scammell
  • Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
    Patent number: 6346548
    Abstract: Modafinil is effective in improving symptoms of attention deficit hyperactivity disorder and symptoms of multiple sclerosis fatigue. The administration of modafinil is also shown to activate the tuberomamillary neurons of the posterior hypothalamus, and thus exhibits activity in an area of the brain associated with normal wakefulness functions.
    Type: Grant
    Filed: August 15, 2000
    Date of Patent: February 12, 2002
    Assignee: Cephalon, Inc.
    Inventors: Matthew S. Miller, Thomas E. Scammell
  • Vitamin D analogues and their neuronal effects
    Patent number: 6207656
    Abstract: The present invention is directed, inter alia, to methods of utilizing low calcemic vitamin D analogues. Particularly, the present invention is directed to using low calcemic vitamin D analogues to treat neurodegenerative diseases and disorders, to facilitate endogenous production of neurotrophic factors, to inhibit the degradation, dysfunction or loss of neural cells and/or to enhance the phenotype of neural cells or neuronal processes.
    Type: Grant
    Filed: May 21, 1998
    Date of Patent: March 27, 2001
    Assignees: Cephalon, Inc., Leo Pharmaceutical Products
    Inventors: Susan Carswell, Pawel Dobrzanski, Lise Binderup, Fredrik Björkling, Matthew S. Miller
  • Use of K-252a derivative
    Patent number: 6184217
    Abstract: Disclosed herein are therapeutic methologies utilizing a ring substituted derivative of the indolocarbazole K-252a, the derivative represented by the formula:
    Type: Grant
    Filed: June 24, 1997
    Date of Patent: February 6, 2001
    Assignee: Cephalon, Inc.
    Inventors: Thomas M Engber, Forrest A. Haun, Michael S. Saporito, Lisa D. Aimone, Matthew S. Miller, Ernest Knight, Jr.
  • Substituted thioacetamides
    Patent number: RE39575
    Abstract: The present invention is directed to chemical compositions of substituted thioacetamides, processes for the preparation thereof and uses of the compositions in the treatment of diseases.
    Type: Grant
    Filed: November 23, 2004
    Date of Patent: April 17, 2007
    Assignee: Cephalon, Inc.
    Inventors: Edward R. Bacon, Sankar Chatterjee, Derek Dunn, John P. Mallamo, Jeffry L. Vaught, Matthew S. Miller